Peter Hoehn

Peter Hoehn is a proven healthcare business leader with 25+ years’ experience in a variety of commercial and strategy roles, predominantly at Johnson & Johnson. Throughout his career Peter has demonstrated the ability to develop insight driven strategies in complex markets and mobilize internal and external partners to achieve results. He brings broad-based commercial, strategy and leadership experiences across Pharmaceuticals, Diagnostics, Digital Health and Precision Medicine, including brand positioning and messaging, reimbursement and market access, global launches, organizational capability building, business model innovation, new opportunity evaluation, business development, and policy.

Peter started his career as a corporate lawyer and entered the pharmaceutical industry as an attorney for Bristol Myers Squibb. After a short time as a lawyer Peter moved into various strategy, marketing and sales management roles at BMS before joining Johnson & Johnson in 2003. He started at J&J as Global Commercial Leader for Reminyl, an Alzheimer’s drug, and was then promoted to Global Marketing Leader, Neurology, where he had global commercial responsibility for in-line neurology products as well as products in late stage of development.

In 2008 Peter joined J&J’s Ortho Clinical Diagnostics organization as Vice President for WW Marketing and Strategic Marketing, responsible for long-term organizational strategy and a large global diagnostics business. In 2012 Peter moved back to J&J’s pharmaceuticals business as Precision Medicine Commercial Strategy Leader. In this role, Peter helped develop J&J’s Precision Medicine strategy, and built and led the Precision Medicine Commercial Team which was responsible for leading strategic marketing and market access for companion and complementary diagnostics across all Therapeutic Areas.

In his most previous role before joining CVB, Peter was Head, Commercial Strategy for J&J Science for Minds, a new organization focused on innovative development models and digital solutions to address Serious Mental Illness and dementia. In this position he developed the strategy, portfolio recommendations, investment approach, external collaborations, and business models for new mental health and brain health digital business ventures.

Peter received a BA in Government and Economics from the College of William and Mary, and a JD from New York University.